Health News

Brazil registered another record number of novel coronavirus deaths over the last 24 hours, the health ministry said on Tuesday evening, as the pandemic in Latin America's largest country shows no signs of slowing down.

The U.S. Food and Drug Administration has extended the review period for Novartis AG's multiple sclerosis drug ofatumumab by three months, the company said on Tuesday.

A senior U.S. Army vaccine researcher said on Tuesday it was reasonable to expect that some sort of coronavirus vaccine could be available to part of the U.S. population by the end of the year.

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday reported a total of 1,802,470 cases of the new coronavirus, an increase of 14,790 cases from its previous count, and said that the number of deaths had risen by 761 to 105,157.

Black and Asian people in England are up to 50% more likely to die after becoming infected with COVID-19, an official study said on Tuesday, putting pressure on the government to outline plans to protect the most at-risk communities.

France's coronavirus death toll rose by more than a 100 for the first time in 13 days on Tuesday, an increase that includes nursing homes data again after a three-day interruption.

A California appeals court on Tuesday heard arguments in the first case that went to trial over allegations that Bayer AG's glyphosate-based weed killer Roundup causes cancer, resulting in a $289 million judgment against the company.

Deysi Silva cannot see, hug or kiss her infant daughter.

U.S. President Donald Trump and Brazilian President Jair Bolsonaro discussed a joint research effort on using the anti-malarial drug hydroxychloroquine as both a prophylaxis and treatment for the coronavirus, the White House said on Tuesday.

The World Health Organization's regional director for the Americas urged the United States on Tuesday to keep helping countries in the region to fight the novel coronavirus even as the Trump administration leaves the U.N. agency.

The Trump administration said this week it will temporarily allow some impurities in alcohol-based hand sanitizer to ensure access to the product during the coronavirus pandemic, reversing course after having tightened restrictions in April.

European Union (EU) nations banking on 5G to boost economic growth are eager to tackle conspiracy theories linking the wireless technology to the spread of the novel coronavirus that have seen masts torched in several places.

Measures taken at a U.S. Air Force base in Texas to curb the spread of the coronavirus resulted less than one percent of its population becoming infected over seven weeks between March and April, U.S. researchers reported on Tuesday.

It is too early to be able to exclude some international travellers from quarantine measures due to be introduced next week to prevent a resurgence of the coronavirus, Britain's COVID-19 testing coordinator said on Tuesday.

Any resurgence of COVID-19 in Britain would probably be local and patchy, testing coordinator John Newton said on Tuesday.

Lonza aims to speed completion of two commercial production lines for Moderna Inc's trial COVID-19 vaccine so manufacturing could start four to six weeks earlier than planned if the project is successful, the Swiss drugmaker's chairman said on Tuesday.

Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed moderate effectiveness for the drug given by infusion.

An outbreak of COVID-19 at a logistics centre run by one of South Korea's largest online shopping companies has raised concerns over whether the virus can be transmitted by package deliveries.

The European Commission on Tuesday started a process that could lead to reforms of drug manufacturing to limit shortages of vaccines and antibiotics and make medicines more easily available.

Pfizer Inc said on Tuesday it will invest up to $500 million into publicly traded drug developers to fund their treatment candidates and provide access to the U.S. drugmaker's scientific expertise.